I am an experienced pharmaceutical research scientist with 10+ years of experience in drug discovery and development at Boehringer Ingelheim, Schering-Plough Research Institute, and Merck Research Labs, with demonstrated success in lead compound identification, target validation, and lead optimization.Key Professional Highlights //-- Core team member in the discovery and development of BACE inhibitor MK-8931, which is currently in human phase III clinical trials for treatment of Alzheimer's Disease.-- Extensive experience in assay development, cell-based assays, protein biochemistry, immunoassay development and biomarker analysis for measuring beta-amyloid peptides and related proteins in CSF, plasma, and brain tissues of rodent, non-human primate and human subjects.-- Experienced in high-throughput compound screening in support of lead optimization using state-of-the-art laboratory automation platforms.